PR

Prestige Biologics Co., Ltd.

A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.

334970 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명1로 197, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Prestige Biologics Co., Ltd. is a global biopharmaceutical Contract Development and Engineering Manufacturing Organization (CDEMO) offering end-to-end solutions for the entire lifecycle of antibody-based therapeutics and other biologics. The company provides a full suite of services, from initial cell line and process development to analytical testing and manufacturing of drug substances and products for both clinical trials and commercial supply. Operating within GMP-compliant facilities, Prestige Biologics also supports clients with secondary packaging, logistics, and transportation for clinical trials, positioning itself as an integrated partner for biopharmaceutical innovators.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Prestige Biologics Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Audit Report / Information
사업보고서 (2025.06)
Korean 493.5 KB
2025-09-18 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-09-15 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 176.8 KB
2025-09-12 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 25.6 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 148.4 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 20.3 KB

Automate Your Workflow. Get a real-time feed of all Prestige Biologics Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prestige Biologics Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP

Talk to a Data Expert

Have a question? We'll get back to you promptly.